Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Thanaputt Chaiyasothi"'
Autor:
Thanaputt Chaiyasothi, Surakit Nathisuwan, Piyameth Dilokthornsakul, Prin Vathesatogkit, Ammarin Thakkinstian, Christopher Reid, Wanwarang Wongcharoen, Nathorn Chaiyakunapruk
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Background: Currently, there is a lack of information on the comparative efficacy and safety of non-statin lipid-lowering agents (NST) in cardiovascular (CV) disease risk reduction when added to background statin therapy (ST). This study determine th
Externí odkaz:
https://doaj.org/article/b35f8ff752454efca2de0715d34ac439
Autor:
Wipharak Rattanavipanon, Thanaputt Chaiyasothi, Punyawee Puchsaka, Rachata Mungkornkaew, Surakit Nathisuwan, Sajesh K. Veettil, Nathorn Chaiyakunapruk
Publikováno v:
British Journal of Clinical Pharmacology. 88:3064-3077
To grade the evidence from published meta-analyses of randomized controlled trials (RCTs) that assessed effects of pharmacist intervention on cardiovascular risk factors and cardiovascular outcomes.MEDLINE, Embase, and the Cochrane Library were searc
Effects of pharmacist interventions on heart failure outcomes: A systematic review and meta‐analysis
Autor:
Surakit Nathisuwan, Mark A. Munger, Ammarin Thakkinstian, Nathorn Chaiyakunapruk, Poukwan Arunmanakul, Arintaya Phrommintikul, Unchalee Permsuwan, Robert L. Page, Kirati Kengkla, Thanaputt Chaiyasothi, Chidchanok Ruengorn
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4:871-882
Autor:
Phatcharin Mitsuntisuk, Nathorn Chaiyakunapruk, Gregory Y.H. Lip, Thanaputt Chaiyasothi, Junporn Kongwatcharapong, Wipharak Rattanavipanon, Khanchit Likittanasombat, Phannita Wattanaruengchai, Arintaya Phrommintikul, Suvatna Chulavatnatol, Duangkamon Kritsanapipat, Surakit Nathisuwan
Publikováno v:
British Journal of Clinical Pharmacology. 87:1390-1400
© 2020 The British Pharmacological Society Aims: This study aimed to evaluate the prescriber compliance to the approved labels of direct oral anticoagulants (DOACs) and impact of appropriateness of dosing on clinical outcomes. Methods: A retrospecti
Autor:
Surakit Nathisuwan, Pornsawan Sirisuwansith, Wipharak Rattanavipanon, Ammarin Thakkinstian, Thanika Pathomwichaiwat, Chonruepat Nithiphongwarakul, Thanaputt Chaiyasothi
Publikováno v:
Phytomedicine : international journal of phytotherapy and phytopharmacology. 88
Background A number of randomized controlled trials (RCTs) have been conducted to evaluate the hypotensive effects of tomato, lycopene, and related products. However, the findings were conflicting, partly due to differences in the types of products i
Autor:
Danny Liew, Nathorn Chaiyakunapruk, Surakit Nathisuwan, Ella Zomer, Khachen Kongpakwattana, Thanaputt Chaiyasothi, Zanfina Ademi
Publikováno v:
PharmacoEconomics. 37(10)
Using non-statin lipid-modifying agents in combination with statin therapy provides additional benefits for cardiovascular disease (CVD) risk reduction, but their value for money has only been evaluated in high-income countries (HICs). Furthermore, s
Autor:
Chidchanok Ruenkon, Mark A. Munger, Robert L. Page, Surakit Nathisuwan, Kirati Kengkla, Nathorn Chaiyakunapruk, Unchalee Permsuwan, Arintaya Phrommintikul, Poukwan Arunmanakul, Thanaputt Chaiyasothi
Publikováno v:
Journal of Cardiac Failure. 26:S121
Introduction Heart failure (HF) is a complex clinical syndrome with a significant economic and health burden. While practice guidelines recommend a multidisciplinary approach in HFrEF care, the impact of pharmacist participation on HF outcomes remain